Venkatesan Jay
SEC insider (Form 3/4/5 filer). CIK 0001413350. Director at Elicio Therapeutics, Inc. (ELTX) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in BOSTON, MA.
Companies Venkatesan Jay has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Director
- Serina Therapeutics, Inc. (SER): Director
Venkatesan Jay
CIK: 0001413350
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 31, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.8K shares- - Jun 17, 2026SER
Serina Therapeutics, Inc.
ConversionIndirect224.2K shares at avg. $2.25$504K - Jun 17, 2026SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - May 22, 2026SER
Serina Therapeutics, Inc.
PurchaseDirect589 shares at avg. $1.78$1K - Mar 31, 2026SER
Serina Therapeutics, Inc.
AwardDirect7.6K shares at avg. $1.94$15K - Nov 7, 2025SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10K shares- - May 19, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.9K shares- - Apr 8, 2025SER
Serina Therapeutics, Inc.
AwardIndirectSeries A Convertible Preferred Stock
96.5K shares at avg. $5.18- - Feb 12, 2025SER
Serina Therapeutics, Inc.
AwardDirectStock Option (right to buy)
40K shares- - Nov 26, 2024ELTX
Elicio Therapeutics, Inc.
In-the-MoneyDirect50K shares at avg. $0.01$500
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,750 | - | - | Direct |
| Jun 17, 2026 |  SER Serina Therapeutics, Inc. | Conversion | 224,152 | $2.25 | $504,342 | Indirect |
| Jun 17, 2026 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 15,250 | - | - | Direct |
| May 22, 2026 | SER Serina Therapeutics, Inc. | Purchase | 589 | $1.78 | $1,048 | Direct |
| Mar 31, 2026 | SER Serina Therapeutics, Inc. | Award | 7,553 | $1.94 | $14,653 | Direct |
| Nov 7, 2025 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| May 19, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,900 | - | - | Direct |
| Apr 8, 2025 | SER Serina Therapeutics, Inc. | Award Series A Convertible Preferred Stock | 96,525 | $5.18 | - | Indirect |
| Feb 12, 2025 | SER Serina Therapeutics, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
| Nov 26, 2024 | ELTX Elicio Therapeutics, Inc. | In-the-Money | 50,000 | $0.01 | $500 | Direct |
1-10 of 13 transactions